AXSM
Axsome Therapeutics, Inc#9 · 2022EPBYearly return
+104%
Peak return
+117%
Max drawdown
-57%
ADR (20 days)
+5.4%
Base
36 days / -46.8%
Prior run
+53%
Breakout volume
30.3x
Pivot
$28.98
Catalyst FDA/Clinical2022-06-28Axsome (AXSM) Surges Following FDA Label Proposal for AXS-05Zacks Investment Research
Biotech-/Medtech-News mit binaerem Daten-, Zulassungs- oder Studiencharakter.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare AXSM with the current market directly.